| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 1116.26 | 96 |
| GSM780708 | Untreated after 4 days (C2_1) | 858.129 | 95 |
| GSM780709 | Untreated after 4 days (C3_1) | 802.999 | 94 |
| GSM780719 | Untreated after 4 days (C1_2) | 1090 | 96 |
| GSM780720 | Untreated after 4 days (C2_2) | 921.418 | 95 |
| GSM780721 | Untreated after 4 days (C3_2) | 828.611 | 95 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 874.647 | 95 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 970.816 | 95 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 997.104 | 96 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 844.863 | 95 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 990.187 | 96 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 1120.81 | 96 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 998.803 | 96 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 862.332 | 95 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 929.48 | 95 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 974.597 | 95 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 875.747 | 95 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 924.791 | 95 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 1110.73 | 96 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 1023.12 | 96 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 926.038 | 95 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 959.116 | 95 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 1020.07 | 96 |